Ultrasound Effects on Glycemic Control in T2DM

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Type 2 Diabetes
Interventions
DEVICE

Ultrasound Delivery

A General Electric LOGIQ E10 ultrasound machine with a C1-6-XD clear probe, will be used to selectively deliver pulsed ultrasound to both, the portal region of the liver and the superior mesenteric plexus.

Trial Locations (1)

06510

RECRUITING

Yale-New Haven Hospital, New Haven

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

Yale University

OTHER

NCT05354947 - Ultrasound Effects on Glycemic Control in T2DM | Biotech Hunter | Biotech Hunter